Trial Profile
A Real-World, Multicenter, Retrospective study to evaluate the safety and efficacy of Calcipotriene/Betamethasone Dipropionate foam 0.005%/0.064% in patients with Plaque psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2018
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 09 May 2018 New trial record